Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS
Keywords: حمل مواد مخدر; Genetic polymorphisms; IGROV-1; HepG2; CaCo-2; LS180 cytochrome P450; Phase II enzymes; Drug transporters